1. Tumor-Infiltrating Lymphocytes as Biomarkers of Treatment Response and Long-Term Survival in Patients with Rectal Cancer: A Systematic Review and Meta-Analysis
   Adile Orhan et al, 2022, Cancers CrossRef
2. Emerging Trends for Radio-Immunotherapy in Rectal Cancer
   Claudia Corrò et al, 2021, Cancers CrossRef
3. IMMUNOREACT 0: Biopsy‐based immune biomarkers as predictors of response to neoadjuvant therapy for rectal cancer—A systematic review and meta‐analysis
   Astghik Stepanyan et al, 2023, Cancer Medicine CrossRef
4. Neoadjuvant immunotherapy for colorectal cancer: Right regimens, right patients, right directions?
   Jiahao Zhu et al, 2023, Frontiers in Immunology CrossRef
5. Germline and Somatic Pharmacogenomics to Refine Rectal Cancer Patients Selection for Neo-Adjuvant Chemoradiotherapy
   Elena De Mattia et al, 2020, Frontiers in Pharmacology CrossRef
6. Debating Pros and Cons of Total Neoadjuvant Therapy in Rectal Cancer
   Francesco Sclafani et al, 2021, Cancers CrossRef
7. The expression pattern of Immune checkpoints after chemo/radiotherapy in the tumor microenvironment
   Hamidreza Hassanian et al, 2022, Frontiers in Immunology CrossRef
8. Histopathological and Haemogram Features Correlate with Prognosis in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiation without Pathological Complete Response
   Yu-Ming Huang et al, 2022, Journal of Clinical Medicine CrossRef
9. The Role of Tumor Microenvironment in Colon Cancer
   Caterina Fattorini et al, 2022, Gastrointestinal Cancers: An Interdisciplinary Approach CrossRef
10. Total neoadjuvant treatment and PD-1/PD-L1 checkpoint inhibitor in locally advanced rectal cancer
    Weiwei Xiao et al, 2023, Frontiers in Immunology CrossRef
11. Tumor microenvironment in non-melanoma skin cancer resistance to photodynamic therapy
    Paulina A. Cerro et al, 2022, Frontiers in Oncology CrossRef